Company: SYRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023235
Chunk: 5

Company: Syra Health Corp
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 1
Chunk 5
---
 -  
     -  
     -  
     -  
     (1,390,256) 
     (1,390,256)

    Balance, June 30, 2024 
     -  
    $-  
     5,769,087  
    $5,769  
     833,334  
    $833  
    $9,987,929  
    $(7,902,261) 
    $2,092,270 
  
    Balance 
     -  
    $-  
     5,769,087  
    $5,769  
     833,334  
    $833  
    $9,987,929  
    $(7,902,261) 
    $2,092,270 

See
accompanying notes to condensed unaudited financial statements.

F-4

SYRA
HEALTH CORP.

CONDENSED
STATEMENTS OF CASH FLOWS

(Unaudited)

    2025  
    2024 

    For the Six Months Ended 

    June 30, 

    2025  
    2024 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net loss 
    $(535,861) 
    $(2,837,306)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation 
     12,775  
     29,919 
  
    Common stock issued for services 
     2,586  
     37,750 
  
    Non-cash lease expense 
     -  
     63,199 
  
    Stock-based compensation, stock options 
     54,067  
     28,486 
  
    Changes in operating assets and liabilities: 

    Accounts receivable 
     (205,534) 
     270,539 
  
    Accounts receivable, related party 
     -  
     (797)
  
    Other current assets 
     157,985  
     148,927 
  
    Right-of-use asset 
     277,029  
     - 
  
    Accounts payable 
     455,366  
     37,123 
  
    Deferred revenue 
     250,000